BillionToOne Is Solving One of Biotech’s Hardest Problems @ycombinator
BillionToOne Is Solving One of Biotech’s Hardest Problems  @ycombinator
Uploaded April 2026 | Updated November 2026, 22 minutes ago
1 in 11 babies born in America this year will be screened by a genetic test that didn't exist a decade ago.

Biotech startup BillionToOne turned a simple but radical idea—detecting rare fragments of fetal DNA in a mother's blood—into one of the most widely used prenatal tests in the U.S. And they're not stopping there. The same approach could unlock something even bigger: early-stage cancer detection from a blood test, a breakthrough that could one day save millions of lives.

In this episode of Hard Tech, YC's Jared Friedman sits down with David Tsao and Oguzhan Atay to hear how they went from half a lab bench to a $4B biotech company—and why they believe this is just the beginning of what their technology can do.

Learn more: billiontoone.com

Chapters:
00:00 – Finding One Mutation in Billions
01:00 – Detecting Disease From a Blood Sample
02:10 – From Lab Idea to $4B Company
03:05 – The Breakthrough That Made It Possible
05:15 – Building the First Test From Scratch
07:30 – One Customer and a Sales Crisis
08:55 – Inside the Lab: How It Actually Works
12:10 – Detecting Cancer From Blood
13:50 – The Path to Early Cancer Detection
16:05 – Why Early Cancer Detection Is So Hard

Apply to Y Combinator: ycombinator.com/apply
Work at a startup: ycombinator.com/jobs
BillionToOne Is Solving One of Biotech’s Hardest ProblemsHard Tech Startups Are Built One Milestone at a TimeWhy Your Startup Website Isnt ConvertingEngineers Make Great FoundersAI-Native Service CompaniesSupply Chain 2.0 for SemiconductorsWhy Inference Matters 12x More Than Training | YC Paper ClubThe Most AI-Pilled CEO We KnowAI-Native Discovery EnginesHow Legora Went From YC to $100M ARR in 18 MonthsWhy Robotics Still Isnt Solved - But Could Be Soon | YC Paper ClubLessons From Training Composer At Cursor And Building Meta/Nvidia Compute Clusters | YC Paper Club
Y Combinator |

BillionToOne Is Solving One of Biotech’s Hardest Problems

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER